New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics
| December 2014 |
Welcome to the December 2014 issue of PharmSource PERISCOPE
This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.
Enjoy the December issue, and happy holidays!
PharmSource Lead Sheet Global Activity Report:
| Lead Type | November 2014 | 2014 YTD |
|---|---|---|
| Early Development | 75 | 897 |
| Late Development | 109 | 1067 |
| Biologic | 77 | 868 |
| Small Molecule | 211 | 2217 |
| Parenteral | 92 | 1001 |
| Oral | 96 | 924 |
| New Financings | 61 | 962 |
| Total Drug Leads | 345 | 3891 |
| Total Device & Diagnostic Leads |
106 | 1588 |
*Total leads include acquisitions/alliances, company acquisition/alliances and events.
Pipeline Tip
ABIVAX completes a Phase I trial with ABX464, a small molecule antiviral, in HIV patients. The company plans to begin a Phase II trial early in 2015. Learn more.
Opportunity Knocks: In-Licensed Drug Products Can Signal Outsourcing Opportunity
In-licensing of NMEs is an important positive signal to the CDMO sector that a candidate is likely to be successful and its manufacture is likely to be outsourced.
Of more than 230 New Molecular Entities (NMEs) approved between 2003-2013, over one-third were in-licensed by the sponsor receiving approval. A significant difference in manufacturing status emerged between products originally discovered in-house and those in-licensed from external partners… More about this Trend Report
Product Alliances: Tip-Offs to New Sales Opportunities
by Blythe Moore, Director, Account Management
In addition to covering the progress of products undergoing clinical trials, the PharmSource Lead Sheet also alerts you to deals between bio/pharma companies in which two companies share in funding the development and commercialization of a drug. These product alliances typically are categorized either as licensing deals or as deals based on specific R&D needs. In addition to summarizing the relationship between the alliance partners, we also display the upfront payment and the total potential value of each deal. It provides you with… read on
Sales Strategy:
Rating the Long-Term Value of Your Clients
If you believe the current “up” selling cycle will continue indefinitely, history says otherwise. And as we’re often reminded, history repeats itself. Will you be ready for change *before* it comes?
Here’s why rating the long-term value of your clients can help you prepare in advance for inevitable change… read on
PharmSource Lead Sheet
The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.
Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.
See for yourself how this resource can be a vital tool for building your brand and growing your market share.
To request a test-drive today, contact Katie Ludwick at kathryn@pharmsouce.com / 1-703-383-4903, ext. 112 (ET USA).